Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
LOS ANGELES, May 21, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded...
-
LOS ANGELES, May 21, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming June 30, 2025 deadline to file a lead plaintiff motion in the class action filed on...
-
LOS ANGELES, May 21, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming July 11, 2025 deadline to file a lead plaintiff motion in the class action filed on...
-
OSE Immunotherapeutics Announces Strategic Collaboration to Pioneer Novel mRNA Technologies OSE Immunotherapeutics to lead French consortium with Inside Therapeutics and MiNT Laboratory (University...
-
KUALA LUMPUR, Malaysia, May 21, 2025 (GLOBE NEWSWIRE) -- Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or the “Company”), a leading e-commerce platform operator, today announced a strategic...
-
Press Release - Approval of all resolutions submitted by the Board of Directors, including the unconsolidated and consolidated financial statements for the year 2024 - Paris – May 21, 2025 – The...
-
PHILADELPHIA, May 21, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”)...
-
MEDIA RELEASE Pyzchiva® first ustekinumab biosimilar in Europe commercially available in pre-filled pen (autoinjector), offering improved self-administration experience for better treatment adherence...
-
Chicago, May 21, 2025 (GLOBE NEWSWIRE) -- The global hemostats market was valued at 2,884.13 million in 2024 and is expected to reach US$ 4,839.68 million by 2033, growing at a CAGR of 5.92% during...
-
EXEL IndustriesA French Société Anonyme with a share capital of €16,969,750Registered office: 54, rue Marcel Paul - 51206 Epernay Cedex - FranceReims Companies Register (RCS): No. 095 550 356 ...